Ottawa, ON June 11, 2003 The Canadian Institutes of Health Research (CIHR) has unveiled a three-part health research strategy on severe acute respiratory syndrome (SARS).
The strategy includes funding of C$1.7 million to four research teams, funding of about $1 million to support related public-health research, and the creation of a research consortium to coordinate, promote and support Canadian research in the area.
Leaders of the four teams funded to a total of $1.7 million are:
– Dr Mark Loeb (McMaster University), whose team will work to improve our understanding of the diagnosis, clinical course, epidemiology and immunopathogenesis of SARS;
– Dr Danuta Skowronski (University of British Columbia), whose team will carry out research leading to the development of a vaccine for SARS;